Business / Health

Add as a preferred source on Google

Stipple Bio Announces Oncology License Deal With Eli Lilly and Company

Stipple Bio announced the agreement on Nov. 16.

Updated 1 min read
A researcher handles oncology assay plates in a Cambridge, Massachusetts biotechnology laboratory. / TokenPost.ai (macro)
A researcher handles oncology assay plates in a Cambridge, Massachusetts biotechnology laboratory. / TokenPost.ai (macro)

Stipple Bio announced an oncology license deal with Eli Lilly and Company on Nov. 16.

The license is exclusive and applies worldwide.

Related articles

View all